Decreased in vitro fluoroquinolone concentrations after admixture with an enteral feeding formulation

Journal of Parenteral and Enteral Nutrition

Volumn 24, Issue 1, 2000, Pages 42-48

  Wright, David H ^a,b   Pietz, Sarah L ^c   Konstantinides, Frank N ^b,c   Rotschafer, John C ^a,b  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Scientific Research Consortium Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CIPROFLOXACIN; ENSURE; LEVOFLOXACIN; MAGNESIUM; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CHEMICAL COMPOSITION; DRUG DEGRADATION; DRUG DETERMINATION; ENTERIC FEEDING; INCUBATION TIME; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

EID: 0033982555     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710002400142     Document Type: Article

References (38)

1. American Society for Parenteral and Enterai Nutrition, Board of Directors: Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 17(suppl):20SA-21SA, 1993
2. Hooper DC, Wofson JW: Fluoroquinolone antimicrobial agents. N Engl J Med 324:384-394, 1991
3. Yuk JH, Williams TW: Drug interactions with quinolone antibiotics in intensive care unit patients (Letter). Arch Intern Med 151:619, 1991
4. Mueller BA, Brierton DG, Abel SR, et al: Effect of enterai feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother 38:2101-2105, 1994
5. Preheim LC, Cuevas TA, Roccaforte JS, et al: Ciprofloxacin and antacids (Letter). Lancet ii:48, 1986
6. Noer BL, Anagaran DM: The effect of enterai feedings on ciprofloxacin pharmacokinetics (Abstr). Pharmacotherapy 10:254, 1990
7. Yuk JH, Nightengale CH, Quintilliani R, et al: Absorption of ciprofloxacin administered through a nasogastric or nasoduodenal tube in volunteers and patients receiving enterai nutrition. Diag Microbiol Infect Dis 13:99-102, 1990
8. Yuk JH, Nightengale CH, Sweeney KR, et al: Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enterai feeding. Antimicrob Agents Chemother 33:1118-1120, 1989
9. Healy DP, Brodbeck MC, Clendening CE: Ciprofloxacin absorption is impaired in patients given enterai feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother 40:6-10, 1996
10. Frost RW, Carlson JD, Dietz AJ, et al: Ciprofloxacin pharmaco-kinetics after a standard or high-fat/high-calcium breakfast. J Clin Pharmacol 29:953-959, 1989
11. Hoffken GH, Lode R, Wiley TD, et al: Reduced enterai absorption of ciprofloxacin and ofloxacin: Effect of food and acid intake. Rev-Infect Dis 10(Suppl 1):S138-S139, 1988
12. Hooper WD, Dickinson RG, Eadie MJ: Effect of food on absorption of lomefloxacin. Antimicrob Agents Chemother 34:1797-1799, 1990
13. Kivisto KT, Ojala-Karlsson P, Neuvonen PJ: Inhibition of nor-floxacin absorption by dairy products. Antimicrob Agents Chemother 36:489-491, 1992
14. Leroy A, Forsa F, Humbert G, et al: The pharmacokinetics of ofloxacin in healthy adult male volunteers. Eur J Clin Pharmacol 31:629-630, 1987
15. Neuvonen PJ, Kivisto KT: Milk and yogurt do not impair the absorption of ofloxacin. Br J Clin Pharmacol 33:346-348, 1992
16. Smogyi AA, Bochner F, Keal JA, et al: Effect of food on enoxacin absorption. Antimicrob Agents Chemother 31:638-639, 1987
17. Sorgel F, Mahr G, Stephan U, et al: Effect of normal and fat-rich food on the absorption of perfloxacin in humans. Rev Infect Dis 10(Suppl 1):S137-S138, 1988
18. Verho M, Malerczyk V, Dagrosa E, et al: The effect of food on the pharmacokinetics of ofloxacin. Curr Med Res Opin 10:166-171, 1986
19. Cabarga MM, Navarro AS, Gandarillas CIC, et al: Effects of two cations on gastrointestinal absorption of ofloxacin. Antimicrob Agents Chemother 35:2102-2105, 1991
20. Kara M, Hasinoff BB, McKay DW, et al: Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol 31:489-491, 1991
21. Polk RE, Healy DP, Sahai J, et al: Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 33:1841-1844, 1989
22. Flor S, Guay DRP, Opsahl JA, et al: Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother 34:9341-9343, 1990
23. Hoffken G, Borner K, Glatzel TD, et al: Reduced enterai absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol 4:345-348, 1985
24. Lomastro BM, Bailie GR: Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother 35:1004-1007, 1991
25. Nix DE, Watson WA, Lerner ME, et al: Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin Pharmacol Ther 46:700-705, 1989
26. Sahai J, Healy DP, Stotka J, et al: The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin. Br J Clin Pharmacol 35:302-304, 1993
27. Shimada JK, Shiba T, Oguma H, et al: Effect of antacid on absorption of the quinolone lomefloxacin. Antimicrob Agents Chemother 36:1219-1224, 1992
28. Garrelts JC, Godley PJ, Peterie JD: Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrob Agents Chemother 34:9341-9343, 1990
29. Parpia S, Nix DE, Hejmanowski LG, et al: Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother 33:99-102, 1989
30. Van Slooten SAD, Nix DE, Wilton JH, et al: Combined use of ciprofloxacin and sucralfate. DICP Ann Pharmacother 25:578-582, 1991
31. Akerle JO, Okhamafe AO: Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics. J Antimicrob Chemother 28:87-94, 1991
32. Lomaestro BM, Bailie GR: Quinolone-cation interactions: A review. DICP Ann Pharmacother 25:1249-1258, 1991
33. Polk RE: Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med 87(Suppl 5A):76S-81S, 1989
34. Sahai JK, Gallicano L, Oliveras S, et al: Cations in the didanosine tablet reduce ciprofloxacin bioavailability. Clin Pharmacol Ther 53:292-297, 1993
35. Noyes M, Polk RE: Norfloxacin and absorption of magnesium-aluminum (Letter). Ann Intern Med 109:168-169, 1988
36. Wright DH, Herman VK, Konstantinides FN, et al: Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography. J Chromatogr B: Biomed Applic 709:97-104, 1998
37. Tanaka M, Kurata T, Fujisawa C, et al: Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob Agents Chemother 37:2173-2178, 1993
38. Shentag JJ, Watson WA, Nix DE, et al: Time dependent interactions between antacids and quinolone antibiotics (Abstr). Clin Pharmacol Ther 43:135, 1988